Primatrix
Device Recon-Skin And Wound
PDI 10381780113744
General payments
$3,388,509
Research payments
$225,578
Through program year 2025, $3,388,509 in general payments and $225,578 in research payments were reported against Primatrix (Recon-Skin And Wound).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $707,434 | 11,190 |
| 2024 | General | $625,508 | 9,198 |
| 2023 | General | $668,387 | 11,192 |
| 2022 | General | $730,851 | 10,992 |
| 2021 | General | $656,328 | 6,116 |
| 2021 | Research | $225,578 | 22 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 127 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 53 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
48,688 general · 22 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.